Experimental pharmacokinetics of RSU-1069 and its analogues: high tumor/plasma ratios
Journal Article
·
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
The mixed-function radiosensitizer RSU-1069 and its analogues possess both alkylating and electron-affinic properties, and have been shown to be more efficient radiosensitizers than misonidazole both in vivo and in vitro. The pharmacokinetics following intraperitoneal injection of three members of this series, RSU-1069, RSU-1164, and RSU-1172 have been studied in C57BL mice bearing B16 melanoma. Peak tumor levels of each compound, and tumor/plasma ratios (T/P) were found to be high: T/P RSU-1069 = 3.8, RSU-1164 = 3.7; RSU-1172 = 4.0. In contrast, other normal tissues including brain showed tissue/plasma ratios close to 1. The mechanisms responsible for differential tumor uptake are unknown, but may depend on the basicity of the compounds, leading to preferential uptake in areas of low pH, or alternatively they may be associated with the alkylating function. This group of compounds appear to demonstrate highly favorable tissue distributions.
- Research Organization:
- Medical Research Council, Chilton, England
- OSTI ID:
- 5004975
- Journal Information:
- Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 7; ISSN IOBPD
- Country of Publication:
- United States
- Language:
- English
Similar Records
RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo
Studies on the mechanisms of the radiosensitizing and cytotoxic properties of RSU-1069 and its analogues
Pharmacology of the mixed-function radio- and chemosensitizers CB 1954 and RSU 1069
Conference
·
Sat Sep 01 00:00:00 EDT 1984
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:6166980
Studies on the mechanisms of the radiosensitizing and cytotoxic properties of RSU-1069 and its analogues
Journal Article
·
Tue Jul 01 00:00:00 EDT 1986
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:5004549
Pharmacology of the mixed-function radio- and chemosensitizers CB 1954 and RSU 1069
Conference
·
Wed Aug 01 00:00:00 EDT 1984
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:6407749
Related Subjects
560152* -- Radiation Effects on Animals-- Animals
560305 -- Chemicals Metabolism & Toxicology-- Vertebrates-- (-1987)
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ANIMALS
ANTINEOPLASTIC DRUGS
AZOLES
DISEASES
DISTRIBUTION
DRUGS
EFFICIENCY
HETEROCYCLIC COMPOUNDS
IMIDAZOLES
MAMMALS
MELANOMAS
MICE
MISONIDAZOLE
NEOPLASMS
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
RADIOSENSITIVITY EFFECTS
RADIOSENSITIZERS
RODENTS
TISSUE DISTRIBUTION
UPTAKE
VERTEBRATES
560305 -- Chemicals Metabolism & Toxicology-- Vertebrates-- (-1987)
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ANIMALS
ANTINEOPLASTIC DRUGS
AZOLES
DISEASES
DISTRIBUTION
DRUGS
EFFICIENCY
HETEROCYCLIC COMPOUNDS
IMIDAZOLES
MAMMALS
MELANOMAS
MICE
MISONIDAZOLE
NEOPLASMS
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
RADIOSENSITIVITY EFFECTS
RADIOSENSITIZERS
RODENTS
TISSUE DISTRIBUTION
UPTAKE
VERTEBRATES